Bank Julius Baer & Co. Ltd, Zurich Vir Biotechnology, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 May 16, 2024	BUY	$7.76 - $10.29 $259,098 - $343,572	33,389 New	33,389 $335,000
Q4 2023 Feb 02, 2024	SELL	$7.76 - $10.29 $69 - $92	-9 Reduced 0.03%	33,389 $336,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $5,995 - $16,150	656 Added 2.0%	33,398 $313,000
Q2 2023 Jul 24, 2023	BUY	$23.2 - $27.29 $759,614 - $893,529	32,742 New	32,742 $803,000
Q1 2023 May 11, 2023	BUY	$22.26 - $30.85 $56,607 - $78,451	2,543 Added 7.46%	36,646 $853,000
Q4 2022 Jan 24, 2023	BUY	$19.96 - $28.22 $44,371 - $62,733	2,223 Added 6.97%	34,103 $863,000
Q3 2022 Nov 04, 2022	SELL	$18.26 - $31.1 $1.19 Million - $2.02 Million	-65,007 Reduced 67.1%	31,880 $615,000
Q2 2022 Jul 22, 2022	SELL	$19.08 - $26.7 $378,986 - $530,342	-19,863 Reduced 17.01%	96,887 $2.47 Million
Q1 2022 May 09, 2022	SELL	$21.19 - $40.01 $397,927 - $751,347	-18,779 Reduced 13.86%	116,750 $3 Million
Q4 2021 Feb 15, 2022	SELL	$30.97 - $54.03 $9.25 Million - $16.1 Million	-298,627 Reduced 68.78%	135,529 $5.68 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $3.44 Million - $5.38 Million	98,644 Added 29.4%	434,156 $18.9 Million
Q2 2021 Jul 23, 2021	BUY	$38.75 - $51.0 $3.24 Million - $4.26 Million	83,516 Added 33.14%	335,512 $15.9 Million
Q1 2021 May 10, 2021	BUY	$26.34 - $83.07 $2.77 Million - $8.74 Million	105,245 Added 71.72%	251,996 $12.9 Million
Q4 2020 Feb 24, 2021	BUY	$25.51 - $43.38 $3.34 Million - $5.69 Million	131,089 Added 836.99%	146,751 $3.93 Million
Q4 2020 Feb 12, 2021	SELL	$25.51 - $43.38 $335,303 - $570,186	-13,144 Reduced 45.63%	15,662 $3.93 Million
Q3 2020 Nov 10, 2020	BUY	$28.28 - $53.6 $814,633 - $1.54 Million	28,806 New	28,806 $989,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$123 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$122 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$97.2 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$41.6 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$26.4 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account